Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • jwfoley
    Senior Member
    • Jun 2009
    • 183

    #1

    Smart-3SEQ: a cheap, fast protocol that is sensitive enough for FFPE single cells

    Our lab has just posted a preprint about our new RNA-seq protocol, Smart-3SEQ. It combines the previous 3SEQ method for 3' digital gene expression and Smart-seq/Smart-seq2 methods for working with very low amounts of input. The resulting protocol is actually simpler and faster than any previous one (~3 hours) and it uses very cheap off-the-shelf reagents (~$5). Combined with relatively inexpensive sequencing conditions (we use fewer than 10M 1x76 nt reads per human sample) it can be very useful for large-scale studies or just for saving money.

    On the small scale, Smart-3SEQ is sensitive and accurate even down to single-cell inputs. Like 3SEQ but unlike Smart-seq/Smart-seq2, it is robust to fragmented RNA, such as from FFPE tissue. In the manuscript we demonstrate this by using Smart-3SEQ to profile single cells extracted from clinical archival tissue, which was not previously possible. Thus Smart-3SEQ enables a range of new studies in molecular pathology and other preclinical research.

    The protocol itself is included with the preprint as Supplemental File 2. It includes special instructions for working with the Arcturus XT laser-capture microdissection system on either fresh or FFPE tissue. I've also attached two spreadsheets for ordering the oligonucleotides from IDT: one that you can copy and paste into the "Bulk Input" tool (the 2S primer must be ordered as Custom RNA and the rest as Custom DNA) and one that you can upload to order the barcoded PCR primers in a 96-well plate (you still need the 1S and 2S from the other file). Note that it may be possible to save more money by ordering the PCR primers with IDT's "Ultramer" synthesis, and then you don't need HPLC purification, plus you might only need one phosphorothioate instead of two - but we haven't tested that yet. The current PCR primers are for 48-plex single-indexing but we're now testing 96-plex unique dual indexes as well.

    Another way to save money on the protocol is to make your own SPRI bead mix.

    I'm happy to answer any questions here about the manuscript, the protocol, LCM, RNA-seq, etc.
    Attached Files
  • luc
    Senior Member
    • Dec 2010
    • 469

    #2
    Thanks for the information Joseph,

    I would have two questions:
    Why should the Smart oligos be 5' biotinylated?
    How much of a balanced library do you need to spike in to sequence through the template-switching Cs without running into read quality problems?

    Thanks in advance!

    Comment

    • jwfoley
      Senior Member
      • Jun 2009
      • 183

      #3
      Both great questions.

      Originally posted by luc View Post
      Why should the Smart oligos be 5' biotinylated?
      Well, first of all, it has nothing to do with streptavidin, which always confuses people, and that's why our diagram (fig. S1 in Supplemental File 1) just calls it a blocking group. Biotin is actually just a very cheap modification to stick on custom oligos. When it's at the 5' end of the primers in template-switching reverse transcription, it prevents the formation of concatamers: if you didn't have it, then at the ends of your ds-cDNA with both adapters on it, you might just extend additional C-tails, and then additional G-overhang primers could come in and anneal again, until by the end your molecule is a series of duplicated adapters at both ends. Biotin seems to be sufficient to stop this, presumably just by steric hindrance. Another solution people have used in the literature is unnatural deoxynucleotides (iso-dC and iso-dG) at the 5' end, which prevent the extension of the unwanted 3' C-tail by maintaining a 3' underhang as there are no complementary dNTPs to pair with them. However, those are a lot more expensive.

      Originally posted by luc View Post
      How much of a balanced library do you need to spike in to sequence through the template-switching Cs without running into read quality problems?
      Actually we have some degenerate bases (N) between the sequencing adapter and the G-overhang, so the resulting reads all begin with NNNNNGGG before the unique cDNA sequence (fig. S3A). This guarantees sequence diversity in the cycles used for cluster registration on Illumina sequencers, so we only use a 1% PhiX spike-in, and that's just in case the sequencer fails and we need to troubleshoot. The NNNNN also serves as a short UMI.

      There can still be some funny business at the beginning of the read, because for three cycles after cluster registration you'll only have G. On the two-color Illumina sequencers in particular, this is read as no signal. So the per-cycle quality graphs look weird. I'm not sure what consequences this has for the 9th cycle, but another thing that can happen is you get more than 3 G's at the beginning, because the C-tailing activity of MMLV RTase doesn't guarantee a particular length. This again screws up the quality metrics, but in practice it doesn't do much harm to the final data because modern read aligners (we used STAR) "soft-clip" non-matching bases at the ends of the read.

      Comment

      • luc
        Senior Member
        • Dec 2010
        • 469

        #4
        Thanks Joseph!
        Have you perhaps tried extending the UMI a bit?

        Comment

        • jwfoley
          Senior Member
          • Jun 2009
          • 183

          #5
          Originally posted by luc View Post
          Have you perhaps tried extending the UMI a bit?
          No, I'm concerned that having a lot of random bases would invite mispriming and other molecular tomfoolery, plus it's a waste of sequencing cycles if you're using short reads, as we do. Oh, and template switching is sensitive to the length of the oligo. Better instead to use a deduplication algorithm that's robust against UMI collisions, but that's a subject for another paper...
          Last edited by jwfoley; 11-03-2017, 03:27 PM. Reason: added another thought

          Comment

          Latest Articles

          Collapse

          • SEQadmin2
            Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
            by SEQadmin2



            CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

            Despite this, “CRISPR helped turn genome editing from a specialized technique into
            ...
            Yesterday, 11:01 AM
          • SEQadmin2
            Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
            by SEQadmin2


            Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

            The systematic characterization of the human proteome has
            ...
            07-20-2026, 11:48 AM
          • SEQadmin2
            Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
            by SEQadmin2



            Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
            ...
            07-09-2026, 11:10 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by SEQadmin2, Yesterday, 02:55 AM
          0 responses
          9 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-24-2026, 12:17 PM
          0 responses
          12 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-23-2026, 11:41 AM
          0 responses
          12 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-20-2026, 11:10 AM
          0 responses
          24 views
          0 reactions
          Last Post SEQadmin2  
          Working...